Bilan Wang
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 10%
Papers in
-
- RNA Interference and Gene Delivery 6
- Protein Degradation and Inhibitors 2
-
- Immunotherapy and Immune Responses 7
- Immune cells in cancer 3
- Co-authors
- Xiang Gao (12 shared papers)Junli Chen (2 shared papers)Yan Teng (2 shared papers)Yuzhu Hu (10 shared papers)Shiqi Hu (1 shared paper)Jianguo Xu (1 shared paper)Haoyuan Wang (1 shared paper)Yongzhong Cheng (1 shared paper)
- Journals
- Signal Transduction and Targeted Therapy (2 papers)Oncotarget (2 papers)Journal of Biomedical Nanotechnology (2 papers)Nanomedicine Nanotechnology Biology and Medicine (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Bilan Wang
16 papers receiving 747 citations
Bilan Wang's Hit Papers
Peers
Comparison fields: 5 of 82
- Biomaterials 195
- Molecular Medicine 41
- Immunology 140
- Biomedical Engineering 274
- Oncology 138
Countries citing papers authored by Bilan Wang
This map shows the geographic impact of Bilan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilan Wang more than expected).
Fields of papers citing papers by Bilan Wang
This network shows the impact of papers produced by Bilan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilan Wang. The network helps show where Bilan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bilan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Current advance of nanotechnology in diagnosis and treatment for malignant tumors Hit paper breakdown → | 2024 | 311 |
| 2 | 2019 | 56 | |
| 3 | 2017 | 52 | |
| 4 | 2020 | 49 | |
| 5 | 2024 | 49 | |
| 6 | 2023 | 41 | |
| 7 | 2018 | 40 | |
| 8 | 2021 | 32 | |
| 9 | 2017 | 27 | |
| 10 | 2021 | 23 | |
| 11 | 2021 | 18 | |
| 12 | 2021 | 15 | |
| 13 | 2017 | 15 | |
| 14 | 2019 | 13 | |
| 15 | 2021 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2020 | 0 | |
| 18 | 2025 | 0 |
About Bilan Wang
Bilan Wang is a scholar working on Molecular Biology, Immunology, Oncology, Biomedical Engineering and Molecular Medicine, having authored 18 papers that have together received 753 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), RNA Interference and Gene Delivery (6 papers), Nanoplatforms for cancer theranostics (4 papers), Immune cells in cancer (3 papers), Curcumin's Biomedical Applications (2 papers), Protein Degradation and Inhibitors (2 papers), Cancer Research and Treatments (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Biomaterials (195 citations), Molecular Medicine (41 citations), Immunology (140 citations), Biomedical Engineering (274 citations) and Oncology (138 citations). Bilan Wang has collaborated with scholars based in China and United States. Frequent co-authors include Xiang Gao, Junli Chen, Yan Teng, Yuzhu Hu, Shiqi Hu, Jianguo Xu, Haoyuan Wang, Yongzhong Cheng, Kaiyu Wang and Ting Yu. Their work appears in journals such as Signal Transduction and Targeted Therapy, Oncotarget, Journal of Biomedical Nanotechnology, Nanomedicine Nanotechnology Biology and Medicine and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.